# QuidelOrtho Corp: financial statements, quarterly

QDEL · Nasdaq · CIK 1906324 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jan 1

Pages: [Overview](/companies/qdel.md) · [Financials](/companies/qdel/financials.md) · [Filings](/companies/qdel/filings.md) · [Insiders](/companies/qdel/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qdel/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [744](/filings/0001906324-24-000049.md) | [743 d](/filings/0001906324-26-000008.md) | [711](/filings/0001906324-25-000057.md) | [637](/filings/0001906324-25-000151.md) | [727](/filings/0001906324-25-000160.md) | [708 d](/filings/0001906324-26-000008.md) | [693](/filings/0001906324-26-000024.md) | [614](/filings/0001906324-26-000033.md) | [700](/filings/0001906324-25-000160.md) | [724 d](/filings/0001906324-26-000008.md) | [620](/filings/0001906324-26-000024.md) | [631](/filings/0001906324-26-000033.md) |
| Research and development | $m | [61.5](/filings/0001906324-24-000049.md) | [59.3 d](/filings/0001906324-26-000008.md) | [59.2](/filings/0001906324-25-000057.md) | [56.3](/filings/0001906324-25-000151.md) | [55.9](/filings/0001906324-25-000160.md) | [47.3 d](/filings/0001906324-26-000008.md) | [53.2](/filings/0001906324-26-000024.md) | [45.7](/filings/0001906324-26-000033.md) | [41.5](/filings/0001906324-25-000160.md) | [45.8 d](/filings/0001906324-26-000008.md) | [44.9](/filings/0001906324-26-000024.md) | [48.7](/filings/0001906324-26-000033.md) |
| Selling, general and administrative | $m | [194](/filings/0001906324-24-000049.md) | [188 d](/filings/0001906324-26-000008.md) | [205](/filings/0001906324-25-000057.md) | [188](/filings/0001906324-25-000151.md) | [186](/filings/0001906324-25-000160.md) | [188 d](/filings/0001906324-26-000008.md) | [187](/filings/0001906324-26-000024.md) | [178](/filings/0001906324-26-000033.md) | [187](/filings/0001906324-25-000160.md) | [194 d](/filings/0001906324-26-000008.md) | [199](/filings/0001906324-26-000024.md) | [190](/filings/0001906324-26-000033.md) |
| Operating income | $m | [26.3](/filings/0001906324-24-000049.md) | [40.1 d](/filings/0001906324-26-000008.md) | [(1,758)](/filings/0001906324-25-000057.md) | [(118)](/filings/0001906324-25-000151.md) | [15.0](/filings/0001906324-25-000160.md) | [(100) d](/filings/0001906324-26-000008.md) | [32.6](/filings/0001906324-26-000024.md) | [(181)](/filings/0001906324-26-000033.md) | [(705)](/filings/0001906324-25-000160.md) | [(66.3) d](/filings/0001906324-26-000008.md) | [(31.8)](/filings/0001906324-26-000024.md) | [(21.8)](/filings/0001906324-26-000033.md) |
| Interest expense | $m | not reported | not reported | [39.0](/filings/0001906324-25-000057.md) | [41.0](/filings/0001906324-25-000151.md) | [42.9](/filings/0001906324-25-000160.md) | [40.6 d](/filings/0001906324-26-000008.md) | [40.0](/filings/0001906324-26-000024.md) | [40.5](/filings/0001906324-26-000033.md) | [46.1](/filings/0001906324-25-000160.md) | [51.0 d](/filings/0001906324-26-000008.md) | [51.1](/filings/0001906324-26-000024.md) | [54.7](/filings/0001906324-26-000033.md) |
| Income tax | $m | [(2.8)](/filings/0001906324-24-000049.md) | [(16.2) d](/filings/0001906324-26-000008.md) | [(92.9)](/filings/0001906324-25-000057.md) | [(15.2)](/filings/0001906324-25-000151.md) | [(8.9)](/filings/0001906324-25-000160.md) | [37.5 d](/filings/0001906324-26-000008.md) | [3.9](/filings/0001906324-26-000024.md) | [25.8](/filings/0001906324-26-000033.md) | [(23.9)](/filings/0001906324-25-000160.md) | [18.3 d](/filings/0001906324-26-000008.md) | [12.3](/filings/0001906324-26-000024.md) | [11.7](/filings/0001906324-26-000033.md) |
| Net income | $m | [(12.7)](/filings/0001906324-24-000049.md) | [7.0 d](/filings/0001906324-26-000008.md) | [(1,706)](/filings/0001906324-25-000160.md) | [(148)](/filings/0001906324-25-000160.md) | [(19.9)](/filings/0001906324-25-000160.md) | [(178) d](/filings/0001906324-26-000008.md) | [(12.7)](/filings/0001906324-26-000033.md) | [(255)](/filings/0001906324-26-000033.md) | [(733)](/filings/0001906324-25-000160.md) | [(131) d](/filings/0001906324-26-000008.md) | [(91.8)](/filings/0001906324-26-000033.md) | [(92.9)](/filings/0001906324-26-000033.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001906324-24-000049.md) | not reported | [(25.50)](/filings/0001906324-25-000057.md) | [(2.20)](/filings/0001906324-25-000151.md) | [(0.30)](/filings/0001906324-25-000160.md) | not reported | [(0.19)](/filings/0001906324-26-000024.md) | [(3.77)](/filings/0001906324-26-000033.md) | [(10.78)](/filings/0001906324-25-000160.md) | not reported | [(1.35)](/filings/0001906324-26-000024.md) | [(1.36)](/filings/0001906324-26-000033.md) |
| Basic EPS | $ per share | [(0.19)](/filings/0001906324-24-000049.md) | not reported | [(25.50)](/filings/0001906324-25-000057.md) | [(2.20)](/filings/0001906324-25-000151.md) | [(0.30)](/filings/0001906324-25-000160.md) | not reported | [(0.19)](/filings/0001906324-26-000024.md) | [(3.77)](/filings/0001906324-26-000033.md) | [(10.78)](/filings/0001906324-25-000160.md) | not reported | [(1.35)](/filings/0001906324-26-000024.md) | [(1.36)](/filings/0001906324-26-000033.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [149](/filings/0001906324-23-000058.md) | [119](/filings/0001906324-25-000035.md) | [78.5](/filings/0001906324-24-000032.md) | [107](/filings/0001906324-24-000045.md) | [144](/filings/0001906324-24-000049.md) | [98.3](/filings/0001906324-26-000008.md) | [127](/filings/0001906324-25-000057.md) | [152](/filings/0001906324-25-000151.md) | [98.1](/filings/0001906324-25-000160.md) | [170](/filings/0001906324-26-000033.md) | [140](/filings/0001906324-26-000024.md) | [123](/filings/0001906324-26-000033.md) |
| Current assets | $m | [1,371](/filings/0001906324-23-000058.md) | [1,311](/filings/0001906324-25-000035.md) | [1,212](/filings/0001906324-24-000032.md) | [1,341](/filings/0001906324-24-000045.md) | [1,413](/filings/0001906324-24-000049.md) | [1,219](/filings/0001906324-26-000008.md) | [1,258](/filings/0001906324-25-000057.md) | [1,282](/filings/0001906324-25-000151.md) | [1,367](/filings/0001906324-25-000160.md) | [1,447](/filings/0001906324-26-000033.md) | [1,377](/filings/0001906324-26-000024.md) | [1,377](/filings/0001906324-26-000033.md) |
| Total assets | $m | [8,539](/filings/0001906324-23-000058.md) | [8,563](/filings/0001906324-25-000035.md) | [6,703](/filings/0001906324-24-000032.md) | [6,689](/filings/0001906324-24-000045.md) | [6,801](/filings/0001906324-24-000049.md) | [6,424](/filings/0001906324-26-000008.md) | [6,462](/filings/0001906324-25-000057.md) | [6,379](/filings/0001906324-25-000151.md) | [5,675](/filings/0001906324-25-000160.md) | [5,769](/filings/0001906324-26-000033.md) | [5,629](/filings/0001906324-26-000024.md) | [5,715](/filings/0001906324-26-000033.md) |
| Current liabilities | $m | [860](/filings/0001906324-23-000058.md) | [834](/filings/0001906324-25-000035.md) | [780](/filings/0001906324-24-000032.md) | [932](/filings/0001906324-24-000045.md) | [1,027](/filings/0001906324-24-000049.md) | [999](/filings/0001906324-26-000008.md) | [1,047](/filings/0001906324-25-000057.md) | [1,142](/filings/0001906324-25-000151.md) | [768](/filings/0001906324-25-000160.md) | [966](/filings/0001906324-26-000033.md) | [962](/filings/0001906324-26-000024.md) | [993](/filings/0001906324-26-000033.md) |
| Total liabilities | $m | [3,572](/filings/0001906324-23-000058.md) | [3,557](/filings/0001906324-25-000035.md) | [3,396](/filings/0001906324-24-000032.md) | [3,516](/filings/0001906324-24-000045.md) | [3,614](/filings/0001906324-24-000049.md) | [3,439](/filings/0001906324-26-000008.md) | [3,464](/filings/0001906324-25-000057.md) | [3,586](/filings/0001906324-25-000151.md) | [3,639](/filings/0001906324-25-000160.md) | [3,849](/filings/0001906324-26-000033.md) | [3,777](/filings/0001906324-26-000024.md) | [3,940](/filings/0001906324-26-000033.md) |
| Long-term debt | $m | not reported | [2,423](/filings/0001906324-24-000043.md) | not reported | not reported | not reported | [2,489](/filings/0001906324-25-000035.md) | not reported | not reported | not reported | [2,698](/filings/0001906324-26-000008.md) | not reported | not reported |
| Current portion of debt | $m | [193](/filings/0001906324-23-000058.md) | [140](/filings/0001906324-25-000035.md) | [161](/filings/0001906324-24-000032.md) | [356](/filings/0001906324-24-000045.md) | [374](/filings/0001906324-24-000049.md) | [342](/filings/0001906324-26-000008.md) | [394](/filings/0001906324-25-000057.md) | [534](/filings/0001906324-25-000151.md) | [163](/filings/0001906324-25-000160.md) | [178](/filings/0001906324-26-000033.md) | [228](/filings/0001906324-26-000024.md) | [356](/filings/0001906324-26-000033.md) |
| Shareholders' equity | $m | [4,967](/filings/0001906324-24-000049.md) | [5,006](/filings/0001906324-26-000008.md) | [3,308](/filings/0001906324-25-000160.md) | [3,174](/filings/0001906324-25-000160.md) | [3,187](/filings/0001906324-25-000160.md) | [2,985](/filings/0001906324-26-000033.md) | [2,997](/filings/0001906324-26-000033.md) | [2,793](/filings/0001906324-26-000033.md) | [2,036](/filings/0001906324-25-000160.md) | [1,921](/filings/0001906324-26-000033.md) | [1,851](/filings/0001906324-26-000033.md) | [1,775](/filings/0001906324-26-000033.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [41.5 d](/filings/0001906324-24-000049.md) | [80.4 d](/filings/0001906324-26-000008.md) | [(0.7)](/filings/0001906324-25-000057.md) | [(97.9) d](/filings/0001906324-25-000151.md) | [118 d](/filings/0001906324-25-000160.md) | [63.7 d](/filings/0001906324-26-000008.md) | [65.6](/filings/0001906324-26-000024.md) | [(46.8) d](/filings/0001906324-26-000033.md) | [(45.5) d](/filings/0001906324-25-000160.md) | [132 d](/filings/0001906324-26-000008.md) | [(33.0)](/filings/0001906324-26-000024.md) | [(111) d](/filings/0001906324-26-000033.md) |
| Capital expenditure | $m | [43.4 d](/filings/0001906324-24-000049.md) | [48.6 d](/filings/0001906324-26-000008.md) | [66.1](/filings/0001906324-25-000057.md) | [35.3 d](/filings/0001906324-25-000151.md) | [46.5 d](/filings/0001906324-25-000160.md) | [47.2 d](/filings/0001906324-26-000008.md) | [56.2](/filings/0001906324-26-000024.md) | [37.5 d](/filings/0001906324-26-000033.md) | [49.2 d](/filings/0001906324-25-000160.md) | [45.3 d](/filings/0001906324-26-000008.md) | [34.0](/filings/0001906324-26-000024.md) | [25.5 d](/filings/0001906324-26-000033.md) |
| Share repurchases | $m | not reported | [7.2 d](/filings/0001906324-26-000008.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.5](/filings/0001906324-23-000058.md) | [67.1](/filings/0001906324-24-000032.md) | [66.8](/filings/0001906324-24-000045.md) | [66.9](/filings/0001906324-24-000049.md) | [66.9](/filings/0001906324-25-000057.md) | [67.1](/filings/0001906324-25-000151.md) | [67.3](/filings/0001906324-25-000160.md) | [67.5](/filings/0001906324-26-000024.md) | [67.7](/filings/0001906324-26-000033.md) | [68.0](/filings/0001906324-25-000160.md) | [68.2](/filings/0001906324-26-000024.md) | [68.3](/filings/0001906324-26-000033.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 68,575,427 at 2026-07-29, from the cover of the [10-Q filed 2026-08-07](/filings/0001906324-26-000033.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.